These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32461120)
21. KSHV targeted therapy: an update on inhibitors of viral lytic replication. Coen N; Duraffour S; Snoeck R; Andrei G Viruses; 2014 Nov; 6(11):4731-59. PubMed ID: 25421895 [TBL] [Abstract][Full Text] [Related]
22. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. Kedes DH; Ganem D J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779 [TBL] [Abstract][Full Text] [Related]
23. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo. Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257 [TBL] [Abstract][Full Text] [Related]
24. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency. Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794 [TBL] [Abstract][Full Text] [Related]
25. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA. Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359 [TBL] [Abstract][Full Text] [Related]
26. iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release. Dollery SJ; Maldonado TD; Brenner EA; Berger EA Front Cell Infect Microbiol; 2021; 11():654396. PubMed ID: 33937098 [TBL] [Abstract][Full Text] [Related]
27. KSHV Genome Replication and Maintenance in Latency. Ueda K Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673 [TBL] [Abstract][Full Text] [Related]
28. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma. Staudt MR; Dittmer DP Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790 [TBL] [Abstract][Full Text] [Related]
29. Regulation of KSHV Latency and Lytic Reactivation. Broussard G; Damania B Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532 [TBL] [Abstract][Full Text] [Related]
30. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452 [TBL] [Abstract][Full Text] [Related]
31. Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK. Chen J; Jiang L; Lan K; Chen X Viruses; 2015 May; 7(5):2268-87. PubMed ID: 25951487 [TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700 [TBL] [Abstract][Full Text] [Related]
34. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication. Uppal T; Meyer D; Agarwal A; Verma SC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255 [TBL] [Abstract][Full Text] [Related]
35. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes. Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B mBio; 2017 Oct; 8(5):. PubMed ID: 29018115 [TBL] [Abstract][Full Text] [Related]
36. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription. Li D; Mosbruger T; Verma D; Swaminathan S J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380 [TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Cathomas G Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339 [TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. Viejo-Borbolla A; Schulz TF AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001 [TBL] [Abstract][Full Text] [Related]
39. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells. Smith CG; Kharkwal H; Wilson DW J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496 [TBL] [Abstract][Full Text] [Related]
40. Kaposi's Sarcoma-Associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus. Yamaguchi T; Watanabe T; Iwaisako Y; Fujimuro M Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]